Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants

This study assesses the durability of protection provided by updated COVID-19 vaccines over a 7-month period, during which circulating SARS-CoV-2 variants were predominantly JN.1 descendants.

Authors

Institutions

Publication Details

Journal
JAMA Internal Medicine
Published
2025-10-27
DOI
https://doi.org/10.1001/jamainternmed.2025.5465
Citations
2
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
2.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants

Yi Du, Yangjianchen Xu, Sai Paritala, Patrick Maloney et al.
2 citations
JAMA Internal Medicine
SARS-CoV-2 and COVID-19 Research
2.79
article

Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants

Yi Du, Yangjianchen Xu, Sai Paritala, Patrick Maloney, Dan-Yu Lin
article en
2 citations

Abstract

This study assesses the durability of protection provided by updated COVID-19 vaccines over a 7-month period, during which circulating SARS-CoV-2 variants were predominantly JN.1 descendants.

JAMA Internal MedicineVol. 185(12)
University of North Carolina at Chapel Hill (US), Nebraska Department of Health and Human Services (US), University of Waterloo (CA), University of Nebraska Medical Center (US)
Openalex Percentile: Top 8%
SARS-CoV-2 and COVID-19 Research
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.